Linc

Linc Cash Flow per Share

The Operating Cash Flow per Share of Linc (LINC.ST) as of Nov 20, 2026 is 0.07 SEK. In the previous year, Operating Cash Flow per Share was 0.51 SEK — a change of -85.66% (lower).

Cash Flow per Share

0.07SEK

YoY

-85.66%

Last updated:

Operating Cash Flow per Share of Linc is 2025 0.07 SEK. Operating Cash Flow per Share of Linc was 2024 0.51 SEK. It decreases by -85.66% lower compared to the previous year.

The Linc Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
-0.34 SEK
Jan 1, 2019
0.02 SEK
Jan 1, 2020
-0.24 SEK
Jan 1, 2021
-7.02 SEK
Jan 1, 2022
-3.94 SEK
Jan 1, 2023
-1.39 SEK
Jan 1, 2024
0.51 SEK
Jan 1, 2025
0.07 SEK
The Linc Cash Flow per Share history
YEARCash Flow per ShareYoY
0.07SEK-85.66%
0.51SEK-136.84%
-1.39SEK-64.69%
-3.94SEK-43.90%
-7.02SEK+2,849.70%
-0.24SEK-1,270.91%
0.02SEK-105.97%
-0.34SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linc Stock analysis

What does Linc do? Linc AB generates revenue through long-term share ownership in Nordic life science companies, focusing on pharmaceutical and medical technology sectors. The company invests in both private and public firms, including early-stage drug development and operational medical technology companies. Linc Invest actively supports portfolio companies by collaborating with management, founders, and boards to unlock growth potential and drive expansion. Its industrial network enables strategic participation in nomination committees and development planning. The firm targets Nordic life science product-oriented companies, prioritizing pharmaceuticals and medical technology. Investments span research and operational phases, with drug development typically occurring earlier than in medical technology. Linc AB maintains a hands-on approach as a long-term owner, leveraging its network to assist portfolio companies in achieving ambitious development goals. Linc AB's business model centers on active ownership and strategic partnerships within the Nordic life science ecosystem. It focuses on companies with strong product pipelines, particularly in pharmaceuticals, where investments often occur during initial development stages. The company's role as a supportive shareholder drives value creation through collaborative governance and targeted expansion strategies. Linc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linc stock

Operating Cash Flow per Share of Linc is 0.07 SEK in 2025.

Operating Cash Flow per Share of Linc changed from 0.51 SEK to 0.07 SEK, representing a -85.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Linc since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Linc

All Key Metrics — Linc